Literature DB >> 34254314

A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy.

Meng Liu1, Xiujie Zhao2, Wenjue Pan2, Zijun Qian2, Mengbao Du1, Li-Mengmeng Wang1,3, He Huang1,3, Haowen Xiao2,3.   

Abstract

Entities:  

Keywords:  zzm321990HNRNPC-RARAzzm321990; acute promyelocytic leukaemia; venetoclax

Mesh:

Substances:

Year:  2021        PMID: 34254314     DOI: 10.1111/bjh.17642

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Clinical Response to Venetoclax and Decitabine in Acute Promyelocytic Leukemia With a Novel RARA-THRAP3 Fusion: A Case Report.

Authors:  Baoquan Song; Xin Wang; Xin Kong; Man Wang; Li Yao; Hongjie Shen; Jian Zhang; Huiying Qiu
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

Review 2.  Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Authors:  Luca Guarnera; Tiziana Ottone; Emiliano Fabiani; Mariadomenica Divona; Arianna Savi; Serena Travaglini; Giulia Falconi; Paola Panetta; Maria Cristina Rapanotti; Maria Teresa Voso
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

3.  Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review.

Authors:  Guangji Zhang; Yang Song; Li Wan; Kaiqi Liu; Shaowei Qiu; Jianxiang Wang; Yingchang Mi
Journal:  Blood Sci       Date:  2022-05-17

4.  Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene.

Authors:  Li Chen; Hongming Zhu; Yongmei Zhu; Wen Jin; Fangyi Dong; Jianfeng Li; Jiong Hu; Qiusheng Chen; Kankan Wang; Junmin Li
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.